Verteporfin Photodynamic Therapy Cohort Study Report 2: Clinical Measures of Vision and Health-Related Quality of Life

Jonathan Reeves, J. Langham, L Walker, Joan Grieve, Usha Chakravarthy, K. Tomlin, J. Carpenter, C. Guerriero, Matthew Harding

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Purpose: To quantify decreases in health-related quality of life (HRQoL) for given deterioration in clinical measures of vision; to describe the shape of these relationships; and to test whether the gradients of these relationships change with duration of visual loss.
Original languageEnglish
Pages (from-to)2463-2470
Number of pages8
JournalOphthalmology
Volume116
Issue number12
DOIs
Publication statusPublished - Dec 2009

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Verteporfin Photodynamic Therapy Cohort Study Report 2: Clinical Measures of Vision and Health-Related Quality of Life'. Together they form a unique fingerprint.

  • Cite this

    Reeves, J., Langham, J., Walker, L., Grieve, J., Chakravarthy, U., Tomlin, K., Carpenter, J., Guerriero, C., & Harding, M. (2009). Verteporfin Photodynamic Therapy Cohort Study Report 2: Clinical Measures of Vision and Health-Related Quality of Life. Ophthalmology, 116(12), 2463-2470. https://doi.org/10.1016/j.ophtha.2009.10.031